@FiercePharma: Allergan joins the patent-loss party in India: Board revokes patents on Ganfort, Combigan glaucoma meds. Report | Follow @FiercePharma
@EricPFierce: Onyx CEO insists there are multiple players at buyout poker table. Reports had said Amgen sat alone. Story | Follow @EricPFierce
@CarlyHFierce: Incredulity turns to praise as malaria vax posts positive PhI data. More from FierceVaccines | Follow @CarlyHFierce
> Amarin ($AMRN) reported a larger loss for the second quarter of the year, despite sales of $5.5 million from its new cholesterol-lowering medicine Vascepa. Story
> Teva Pharmaceutical Industries ($TEVA) has gotten authorization from the European Commission to market Lonquex (lipegfilgrastim) for treating neutropenia and the incidence of febrile neutropenia in some adults getting chemotherapy. Release
> Actavis ($ACT) has gotten approval from French authorities for its acquisition of Warner Chilcott ($WCRX). Item
> A lawsuit has been filed against a law in Oklahoma that bans girls under the age 17 from getting Teva's morning-after contraceptive pill. Story
> A grant may help developers get to the market by 2015 with a smart pill bottle that notifies patients to take their meds. Story
@FierceMedDev: Zimmer owes Stryker $228M in patent lawsuit. News | Follow @FierceMedDev
@DamianFierce: Meet Verizon Wireless, medical device manufacturer. Story | Follow @DamianFierce
@MichaelGFierce: GE, U. of Wash. team up to make paper-based diagnostics device. Article | Follow @MichaelGFierce
> Alere wins FDA nod for HIV test, struggles on the Street. Report
> SightLine raises $107M fund for med tech investments. Item
Biotech News
@FierceBiotech: Popular yesterday: Upsized Intrexon IPO delivers another blockbuster success for billionaire Kirk. Story | Follow @FierceBiotech
@JohnCFierce: Over the past month 7 biotechs have raised $562M from IPOs. Brings the year's total so far to more than $2B. | Follow @JohnCFierce
@RyanMFierce: Ariad Pharma denied FDA's coveted 'breakthrough' stamp for lung cancer drug. News | Follow @RyanMFierce
@EmilyMFierce: NIH and Lacks family decision to open genomic data of HeLa cells to researchers will also establish genome database. Article | Follow @EmilyMFierce
> FDA deals Novo Nordisk another setback for hemophilia therapy. Report
> Is the biotech IPO frenzy headed for a crack-up? Editor's Corner
And Finally... A study finds that for the second year in a row, oncologists are the hardest doctors for pharma sales reps to get facetime with. Story